Latest filing published 09 Jun 2026 for Ligand Pharmaceuticals INC.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Nancy Ryan Gray: trading record in brief
Nancy Ryan Gray is a declared insider of Ligand Pharmaceuticals Inc (board member), with filings sourced from SEC (Form 4). In total, 15 filings cover trades dated from 18 August 2017 to 5 June 2026.
On the market, this insider has only sold: 3 sales, €1.2M in total. Besides market trades, the filings include 10 share grants and 2 option exercises.
On 9 June 2026 came the latest disclosure, a share grant in Ligand Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Nancy Ryan Gray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 836 shares0Common StockSEC:0002001011-26-000096:0
- 3,556 shares@ US$66.1973.9% of flowCommon StockSEC:0002001011-25-000098:0
- 1,209 shares0Common StockSEC:0002001011-25-000046:0
- 1,252 shares0Common StockSEC:0002001011-24-000056:0
- 934 shares@ US$83.2049100.0% of flowCommon StockSEC:0002001011-24-000054:0
- 1,142 shares0Common StockSEC:0000886163-23-000043:0
- 1,004 shares0Common StockSEC:0000886163-22-000081:0
- 630 shares0Common StockSEC:0000886163-21-000091:0
8 of 8 declarations
